BioSpace News Archive

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for OLX104C, an investigational therapeutic for the treatment of androgenic alopecia, also known as male pattern baldness.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Rosemary A. Crane to its Board of Directors.

CooperCompanies, announced that the Chinese National Medical Products Administration, which regulates medical devices and pharmaceuticals in China, has approved CooperVision MiSight® 1 day contact lenses for use within the country following a priority review.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today reported financial and corporate results for its second quarter ended June 30, 2021.

FEops, a leader in predictive planning for structural heart interventions, is proud to announce that its simulation technology supported TRiCares from initial design concept to a successful first-in-human of the Topaz Tricuspid Valve Replacement (TTVR) system, developed by TRiCares SAS.

Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2 diabetes, latest research suggests.

miR Scientific, LLC announces the appointment of Erik Johnson, a seasoned leader in pharma and oncology, as Chief Operating Officer.

Fujifilm Corporation, a global medical imaging device provider, announced its AI-powered product for analyzing chest X-ray ‘CXR-AID’ will be commercially available across Japan.

The report highlights trends prevailing in the global respiratory ventilator tester market, and the drivers and restraints pertaining to the market growth.

The global point of care diagnostics market is expected to reach US$ 70.89 Bn in 2027 from US$ 26.60 Bn in 2018.